A survey of National Cancer Institute-designated comprehensive cancer centers’ oral health supportive care practices and resources in the USA
- First Online:
The oral complications and morbidity resulting from overall cancer therapy utilizing radiation, chemotherapy, and/or stem cell transplantation can have significant impact on a patient’s health, quality of life, cost of care, and cancer management. There has been minimal health services research focusing on the status of medically necessary, oral supportive services at US cancer centers.
A pre-tested, survey questionnaire was distributed to the directors of National Cancer Institute (NCI)-designated comprehensive cancer centers to assess each institution’s resource availability and clinical practices, as it relates to the prevention and management of oral complications during cancer treatment.
Sixteen of the 39 comprehensive cancer centers responded to the survey. Of the respondents, 56% of the centers did not have a dental department. The sites of delivery of oral supportive care services range from the provision of in-house dental care to community-based, private practice sites. No standard protocols were in place for either oral preventive care or for supportive services for oral complications during or after cancer therapy. Fifty percent of the responding comprehensive cancer centers reported orally focused research and/or clinical trial activities.
Comprehensive cancer care must include an oral care component, particularly for those cancer patients who are at high risk for oral complications. This requires a functional team of oral care providers collaborating closely within the oncology team. Considering the number of cancer patients receiving aggressive oncologic treatment that may result in oral toxicity, the impact of oral conditions on a compromised host, and the potential lack of appropriate resources and healthcare personnel to manage these complications, future research efforts are needed to identify the strengths and weaknesses of present oral supportive care delivery systems at both NCI-designated cancer centers and community-based oncology practices.
KeywordsOral/dental care Oncology Comprehensive cancer centers
- 3.Rose-Ped A, Belim LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ (2002) Complications of radiation therapy for head and neck cancers. Cancer Nurs 25:462–467Google Scholar
- 5.Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Mucositis study section of the multinational association for supportive care in cancer; International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026–2046PubMedCrossRefGoogle Scholar
- 6.Sonis ST, Oster G, Fuchs H, Belim L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201–2205PubMedGoogle Scholar
- 13.Duncan GG, Epstein JB, Tu D, Sayed SE, Bezjak A, Ottaway J, Pater J (2005) Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck 27(5):421–428PubMedCrossRefGoogle Scholar
- 15.Institute of Medicine Report (1995) Dental education at the crossroads. National Academy Press, Washington, District of Columbia (2000)Google Scholar
- 16.Oral complications of cancer therapies: diagnosis, prevention and treatment (1990). NCI Monogr 9:3–8Google Scholar
- 17.US Department of Health and Human Services (2000) Oral health in America: a report of the Surgeon General. Rockville, Maryland: US Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, 2–3Google Scholar